Stockreport

Arch Therapeutics to Provide Corporate Update at the H.C. Wainwright 21st Annual Global Investment Conference

Arch Therapeutics, Inc.  (ARTH) 
NASDAQ:AMEX Investor Relations: ir.archtherapeutics.com
PDF FRAMINGHAM, Mass., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemosta [Read more]